Glucose Transport Dependency Defines a Therapeutic Vulnerability in Myeloproliferative Neoplasms
RNA-seq (gene expression) · mouse · 8 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 8 samples: 2 × 32D Jak2WT cells, GLUT1/3 WT, clone vs 2 × 32D Jak2WT cells, GLUT1/3 KO, clone vs 2 × 32D Jak2V617F cells, GLUT1/3 WT, clone vs 2 × 32D Jak2V617F cells, GLUT1/3 KO, cloneGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasmsCell communication and signaling : CCS · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE319980_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1425924 and SRA study SRP678206. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 8 samples.
How we read this: 4 replicated groups read from 8 sample titles; they account for 8 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9530729 32D Jak2WT cells, GLUT1/3 WT, clone 1 32D Jak2WT cells, GLUT1…
- GSM9530730 32D Jak2WT cells, GLUT1/3 WT, clone 3 32D Jak2WT cells, GLUT1…
- GSM9530731 32D Jak2WT cells, GLUT1/3 KO, clone 1 32D Jak2WT cells, GLUT1…
- GSM9530732 32D Jak2WT cells, GLUT1/3 KO, clone 3 32D Jak2WT cells, GLUT1…
- GSM9530733 32D Jak2V617F cells, GLUT1/3 WT, clone 1 32D Jak2V617F cells, GL…
- GSM9530734 32D Jak2V617F cells, GLUT1/3 WT, clone 3 32D Jak2V617F cells, GL…
- GSM9530735 32D Jak2V617F cells, GLUT1/3 KO, clone 1 32D Jak2V617F cells, GL…
- GSM9530736 32D Jak2V617F cells, GLUT1/3 KO, clone 3 32D Jak2V617F cells, GL…
- GSE223323 Enterocyte like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability 148 samples shares vulnerability, therapeutic, defines
- GSE308233 JAK2V617F Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones 16 samples shares myeloproliferative, neoplasms
- GSE282977 Alpha-ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia [KL974_shOGDH] 14 samples shares vulnerability, therapeutic
- GSE266091 Asxl1 mutation enhances differentiation in CSF3R-mutated myeloproliferative neoplasms [RNA-Seq] 12 samples shares myeloproliferative, neoplasms
- GSE327213 Increased mRNA translation delays tumor initiation and exposes a therapeutic vulnerability in lung cancer 16 samples shares vulnerability, therapeutic
- GSE266087 Asxl1 mutation enhances differentiation in CSF3R-mutated myeloproliferative neoplasms [ATAC-Seq] 12 samples shares myeloproliferative, neoplasms
- GSE307773 Oncogenic MAPK signalling induces epithelial cell state change and therapeutic resistance in vivo [RNA-Seq] 175 samples shares therapeutic
- GSE330865 Multiorgan transcriptomics and circulating extracellular vesicle profiling reveal age-dependent systemic vulnerability to isoflurane anesthesia and surgery 120 samples shares vulnerability
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.